FDA Investigator Gary C Pecic, Jr

Gary C Pecic, Jr has conducted inspections on 77 sites in 2 countries as of 23 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
77
Last Inspection Date:
23 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100000348
Countries of Inspections:
United States of America, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Gary C Pecic, Jr:
Alan Escalona, Alan M Barker, Alicia A Armijo, Allison V Bonnenburg, Amanda S Zorn, Amy L Mcintyre, Andrea J Schmidt, Andrew K Haack, PhD, Andrew M Kolenc, Angela Mock, Anita Narula, PhD, Antonetta M Colacchio, Aric M Sonnenschein, Arturo De La Garza, Aryonna M Renouf, Ashley M Caputo, Azotearc, Barbara Janine Breithaupt, Blake R Jensen, Bodenw, Brandon M Kurjanowicz, Brenda Chavez, Brent W Higgs, Brian D Nicholson, Brian P Hendrickson, Brian R Yaun, Bruce W Benware, Bryan A Galvez, Bryan L Mcguckin, Carla R Hinz, Carmen Ramirez, Carolyn J Cook, Carrie E Jolly, Charles B Steinmiller, Cheryl D Mccall, Christin L Torres, Christina A Mayer, Christine L Williams, Christopher M Jenner, Christopher R Czajka, Ciara J Bajulai Austin, Daniel Pst Laurent, David A Gonzalez, David J Leray, Debra A Taylor, Debra L Curtis, Devon Jenkins, Donald R Hawn, Duc Minh H Nguyen, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Elizabeth P Mayer, Elvin R Smith, Emilie E Kahn, Emily J Orban, Eric R Holm, Erica R Havely, Erica R Woody, Farhana Khan, Felicia M Orlando, Felix J Marrero, Garrad R Poole, Gerard Pde Leon, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Grace E Mcnally, Hanna L Potter, Harry A Wilson, Holly J Smith, Holly L Miller, Howard A Webley, Hung V Le, Isabel Y Espinosa, Ivy Z Bevill, Jacob W Reynolds, James D Romero, James P Stallings, Jamie L Port, Jennifer A Baker, Jennifer A Robinson, Jennifer M Heitz, Jennifer M Pouget, Jennifer R Mathern, Jennifer S Arce, Jessica M Ector, Jessica M Monteiro, Jessie E Morris, John A Daubenspeck, Joshua A Querl, June P Page, Justin H Erickson, Ka L Wong, Kamara Co, Karen M Labounty, Kathleen S Tormey, Kathryn M Mogen, Kawshalya Pathiraja, Keith C Littrell, Kenneth O Gee, PhD, Kenneth S Boehnen, Khumo A Phake, Kibily D Dembele, Kimberley A Hoefen, Kristen E Szenderski, Larisa E Pavlick, Laura A Munsterman, Laura B Kennedy, Laura L Van Wagenen, Lavender M Huskey, Leon R Stratman, Linda M Cheny, Lisa T Michel, Lucas B Leake, Manuel A Moreno, Marea K Harmon, Margaret M Sands, Margo C Jones, Marie B Buen Bigornia, Marion W Nadeau, Mark Miller, Marsha L Mccauley, Marvin D Jones, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew R Dionne, Meaghan M Rabideau, Meisha R Sampson, Meisha Waters, Meredith L Sheridan, Michael R Goga, Michelle D Motsinger, Mikayla K Deardorff, Mikayla K Turner, Moonn, Morie Alpha, Nancy E Byerly, Narahi J Alvarez Alcazar, Natalie J Ayoub, Nathan R Moon, Nianna C Burns, Nianna M Capalia, Nicholas A Cogdall, Nicholas Fragedakis, Nora W Kabbara, Oluwaseyi Ojinni, Patricia A Brown, Patricia A Maestas, Patricia P Wrona, Paul Klug, Paul Z Balcer, Peter Kessler, PhD, Philip E Ake, Ramanda C Gregory, Rebecca S Secrist, Ricki A Chase, Robert J Goldman, Rochelle A Rolnik, Roger J Adams, Russell J Glapion, Russell K Riley, Samantha E Rafferty, Sangeeta M Khurana, PhD, Sara Jdent Acosta, Sarah M Meng, Sarah M Napier, Secrist, Shane R Teeter, Sheila Alaghemand, Shererk, Siobhan A Gallagher, Siobhan G Taylor, Solomon G Williams, Stephen T Hansen, Steve P Yost, Tamayo C Barnes, Thai T Duong, Thanh M Andrews, Theressa B Smith, Thomas V Anderson, Timothy T Kapsala, Toni L Morales, Tracy K Li, Trevor R Beach, Vernon L O'neil, William D Boden, Yaw O Osei

Gary C Pecic, Jr's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center - Form 483, 2017-03-08
May, 2015 FDA 483 Montana Compounding Pharmacy PC - Form 483, 2015-05-08
March, 2016 EIR Pharmakon Pharmaceuticals, Inc. - EIR, 2016-03-16
May, 2016 FDA 483 Ballard Plaza Pharmacy I, Inc. - Form 483, 2016-06-10
July, 2015 FDA 483 Kalman Health & Wellness, Inc. - Form 483, 2015-07-21
November, 2020 FDA 483 Russ Davis Wholesale, Inc. - Form 483, 2020-12-14
March, 2016 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2016-03-16
March, 2017 FDA 483 Response Compound Preferred LLC - Form 483R, 2017-03-22
October, 2015 FDA 483 Response Advanced Infusion Solutions - Form 483R, 2015-11-20
May, 2023 FDA 483 Abbott Laboratories Inc. - Form 483, 2023-06-07
March, 2017 FDA 483 Compound Preferred LLC - Form 483, 2017-03-01
October, 2015 FDA 483 Advanced Infusion Solutions - Form 483, 2015-10-27
May, 2016 FDA 483 Response Amniotic Therapies LLC. - Form 483R, 2017-06-07
January, 2019 FDA 483 Meadow Gold LLC - Form 483, 2019-01-29
August, 2021 FDA 483 Good Health Manufacturing - Form 483, 2021-08-20
May, 2016 FDA 483 Amniotic Therapies LLC. - Form 483, 2016-05-24
December, 2021 FDA 483 Phoenix Formulations - Form 483, 2021-12-03
November, 2023 FDA 483 Creation Gardens, Inc. - Form 483, 2023-11-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more